InterMune Inc. (ITMN) France's Economic Committee (CEPS) Authorizes Reimbursement of Esbriet Conference Call September 11, 2012, 08:00 am ET Executives Jim Goff - VP, Corporate Communications & IR Dan Welch - Chairman, CEO and President Giacomo Di Nepi - SVP and Managing Director, Europe Analysts Brian Abrahams - Wells Fargo Securities Ritu Baral - Canaccord Katherine Xu - William Blair Michael Yee - RBC Capital Markets Geoff Meacham - JPMorgan Terence Flynn - Goldman Sachs Matthew Harrison - UBS Liisa Bayko - JMP Securities PresentationOperator
Ladies and gentlemen thank you for standing by. Welcome to the Esbriet Reimbursement in France conference call. During the presentation all participants will be in a listen-only mode. Afterwards will conduct a question-and-answer session. (Operator Instructions) As a remainder this conference is being recorded today Tuesday September 11, 2012. I will now like to turn the conference over to Jim Goff VP Investor Relations for InterMune. Please go ahead, sir. Jim Goff Thank you operator. Good morning everyone and welcome to this InterMune conference call. This morning we issued a press release that discusses the pricing, the reimbursement and launch timing of Esbriet in France. That press release is available on our website at www.intermune.com. During the course of this conference call we will state our beliefs and make projections and other forward-looking statements regarding future events and the future financial performance of InterMune and wish to caution you that such statements or predictions and expectations and actual events are results that may differ materially. We refer you to the company's publicly filed SEC disclosure documents for a detailed description of the risk factors affecting our business including those discussed in our Form 10-K filed with the SEC on February 29 2012 and Form 10-Q filed with the SEC on august 8 2012.